Neuberger Berman Group
RVMD icon

Neuberger Berman Group’s Revolution Medicines RVMD Stock Holding History

Neuberger Berman Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5M Buy
109,221
+89,103
+443% +$13M 0.01% 712
2026
Q1 		$1.96M Buy
20,118
+1,760
+10% +$178K ﹤0.01% 1192
2025
Q4 		$1.46M Buy
18,358
+1,063
+6% +$69.7K ﹤0.01% 1280
2025
Q3 		$808K Sell
17,295
-100,869
-85% -$3.95M ﹤0.01% 1433
2025
Q2 		$4.35M Sell
118,164
-59,918
-34% -$2.3M ﹤0.01% 1003
2025
Q1 		$6.3M Buy
178,082
+31,425
+21% +$1.28M 0.01% 888
2024
Q4 		$6.41M Buy
146,657
+13,204
+10% +$666K 0.01% 898
2024
Q3 		$6.05M Sell
133,453
-8,634
-6% -$376K ﹤0.01% 898
2024
Q2 		$5.51M Sell
142,087
-1,272
-0.9% -$47.5K ﹤0.01% 892
2024
Q1 		$4.62M Sell
143,359
-28,205
-16% -$836K ﹤0.01% 948
2023
Q4 		$4.92M Buy
+171,564
New +$4.12M ﹤0.01% 1069

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Neuberger Berman Group's RVMD Position: Q2 2026 in Review

Neuberger Berman Group increased its Revolution Medicines (RVMD) stake by 443% in Q2 2026, buying an estimated $13M and bringing the position to 109,221 shares worth $20.5M. The position accounts for 0.01% of the portfolio, ranked #712.

Neuberger Berman Group first reported a position in RVMD in Q4 2023 and has held it in 11 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Neuberger Berman Group held 109,221 shares of Revolution Medicines worth $20.5M as of Q2 2026.
  • Neuberger Berman Group bought 89,103 Revolution Medicines shares in Q2 2026, an estimated $13M.
  • Revolution Medicines made up 0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #712 holding.
  • Neuberger Berman Group first reported a position in Revolution Medicines in Q4 2023 and has held it in 11 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.